Drugs / ACTH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01028287 Comparator | May 2009 → Dec 2010 | diabetic kidney disease, nephrotic syndrome | Southeast Renal Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01028287 ↗ |
| Action | Activate | “through activation of melanocortin receptors (MCR) expressed in the podocyte” PMID 24159603 ↗ Sep 2013 |
| Route | Subcutaneous | “daily subcutaneous (SQ) injections of 16 or 32 units of ACTH gel” PMID 24159603 ↗ Sep 2013 |